1. Home
  2. INTS vs CENN Comparison

INTS vs CENN Comparison

Compare INTS & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • CENN
  • Stock Information
  • Founded
  • INTS 2012
  • CENN 2013
  • Country
  • INTS United States
  • CENN United States
  • Employees
  • INTS N/A
  • CENN N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • INTS Health Care
  • CENN Consumer Discretionary
  • Exchange
  • INTS Nasdaq
  • CENN Nasdaq
  • Market Cap
  • INTS 7.4M
  • CENN 30.4M
  • IPO Year
  • INTS 2023
  • CENN N/A
  • Fundamental
  • Price
  • INTS $0.33
  • CENN $0.68
  • Analyst Decision
  • INTS Strong Buy
  • CENN
  • Analyst Count
  • INTS 3
  • CENN 0
  • Target Price
  • INTS $8.50
  • CENN N/A
  • AVG Volume (30 Days)
  • INTS 3.7M
  • CENN 522.4K
  • Earning Date
  • INTS 08-07-2025
  • CENN 08-12-2025
  • Dividend Yield
  • INTS N/A
  • CENN N/A
  • EPS Growth
  • INTS N/A
  • CENN N/A
  • EPS
  • INTS N/A
  • CENN N/A
  • Revenue
  • INTS N/A
  • CENN $31,097,533.00
  • Revenue This Year
  • INTS N/A
  • CENN N/A
  • Revenue Next Year
  • INTS N/A
  • CENN N/A
  • P/E Ratio
  • INTS N/A
  • CENN N/A
  • Revenue Growth
  • INTS N/A
  • CENN 234.45
  • 52 Week Low
  • INTS $0.26
  • CENN $0.61
  • 52 Week High
  • INTS $5.10
  • CENN $1.84
  • Technical
  • Relative Strength Index (RSI)
  • INTS 41.29
  • CENN 40.63
  • Support Level
  • INTS $0.26
  • CENN $0.61
  • Resistance Level
  • INTS $0.32
  • CENN $0.76
  • Average True Range (ATR)
  • INTS 0.03
  • CENN 0.08
  • MACD
  • INTS 0.02
  • CENN -0.01
  • Stochastic Oscillator
  • INTS 62.56
  • CENN 15.29

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: